However, using TMAs with a single spot per cancer, we have been able to reproduce a multitude of established associations between clinical features and molecular markers such as HER2 (Barlund et al. 2000), Vimentin (Moch et al. 1999) and Ki67 (Ruiz et al. 2006) in the past. This evidence concerns the gene ERBB2 and cancer.